Wound bed cells and extracellular matrix

The wound bed cells and extracellular matrix (ECM) constitute the dynamic microenvironment essential for cutaneous tissue repair and regeneration (StatPearls, 2023). This complex milieu comprises various cell populations, including fibroblasts, keratinocytes, endothelial cells, and infiltrating leukocytes, all interacting within a structural framework of fibrous proteins like collagen, elastin, and laminin (NCBI Bookshelf, 2022). The ECM serves as a reservoir for signaling molecules and provides the mechanical cues necessary for cell adhesion, migration, and differentiation during the phases of healing (Journal of Cell Science, 2020). In chronic or non-healing wounds, this environment is often compromised by excessive protease activity, such as matrix metalloproteinases, and persistent inflammation (PubMed, 2021). Pharmacological and regenerative strategies targeting the wound bed aim to restore homeostasis by modulating the inflammatory response, promoting angiogenesis, and providing structural support to facilitate closure (Nature Reviews Disease Primers, 2022). Because this term describes a tissue environment rather than a discrete molecular entity, it is generally classified as a therapeutic site or microenvironment rather than a specific drug target.

Other names

Wound microenvironmentGranulation tissueWound bedDermal extracellular matrixWound site

Therapeutic agents acting on the wound bed typically function through enzymatic debridement of necrotic tissue, stimulation of cellular proliferation via growth factor pathways (e.g., PDGF signaling), or by providing a physical scaffold for cell migration and tissue integration (StatPearls, 2023; FDA, 2023).